Literature DB >> 24333666

Evaluation of Shirasu Porous Glass (SPG) membrane emulsification for the preparation of colloidal lipid drug carrier dispersions.

Sonja Joseph1, Heike Bunjes2.   

Abstract

Aqueous colloidal drug carrier dispersions based on nonpolar lipids are usually prepared by high energy dispersion techniques, like high-pressure homogenization. Homogenization generates high shear forces and may thus not be suitable for the processing of sensitive pharmaceutical ingredients, e.g., proteins. This study investigated the general possibility to prepare lipid nanoparticle dispersions by direct and premix Shirasu Porous Glass (SPG) membrane emulsification as alternative low energy and low shear method. The influence of different emulsifiers (polysorbate 20, sorbitan oleate, poloxamer 188, sodium dodecyl sulfate, sucrose laurate), the type of lipid phase (medium chain triglycerides, soybean oil, trimyristin, glyceryl behenate, lauroyl macrogolglycerides), the pore size of the SPG membrane (0.1, 0.2, 0.3, 0.5, 1.1μm) and the emulsifying pressure on the particle size of the resulting dispersions was investigated. The particle size was primarily controlled by the pore size of the membrane and the emulsifying pressure. Very narrow particle size distributions with membrane pore size/mean particle size ratios of 1:0.4-1:8.2 and 1:0.4-1:2.1 were observed for the direct and the premix membrane emulsification method, respectively. Due to the comparatively lower process pressures of at maximum 10bar SPG membrane emulsification is an interesting alternative method to high-pressure homogenization.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colloidal lipid dispersions; Direct membrane emulsification; Nanoemulsions; Premix membrane emulsification; SPG (Shirasu Porous Glass) membranes; Solid lipid nanoparticles

Mesh:

Substances:

Year:  2013        PMID: 24333666     DOI: 10.1016/j.ejpb.2013.11.010

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice.

Authors:  Qiuzhen Liang; Haibin Xiang; Xinyu Li; Chunxia Luo; Xuehong Ma; Wenhui Zhao; Jiangtao Chen; Zheng Tian; Xinxia Li; Xinghua Song
Journal:  Int J Nanomedicine       Date:  2020-10-06

2.  Effect of Bufalin-PLGA Microspheres in the Alleviation of Neuropathic Pain via the CCI Model.

Authors:  Lina Long; Wenwei Zhong; Liwei Guo; Jing Ji; Hong Nie
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  Premix Membrane Emulsification: Preparation and Stability of Medium-Chain Triglyceride Emulsions with Droplet Sizes below 100 nm.

Authors:  Lara El-Hawari; Heike Bunjes
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.